The Critical Role of Monoclonal Antibodies as the COVID-19 Pandemic Continues

COURSE DESCRIPTION | SPEAKER | PANELISTS | COST | REGISTRATION

In the continued fight against the virus that causes COVID-19, we have seen how important monoclonal antibodies and other therapeutics are in helping prevent serious illness. As viral variants arise and spread, it is increasingly critical that healthcare providers who care for people at increased risk of developing severe COVID-19 symptoms have the latest treatment information at their fingertips.

Dr. John Redd, with the HHS Office of the Assistant Secretary for Preparedness and Response, will share the latest information on the available COVID-19 therapeutics and address important updates such as the efficacy of the medications, new administration routes and novel treatments in the pipeline, fee reimbursement resources, provider and patient tools and fact sheets, and much more.  Dr. Redd and his colleagues, Gina Smith and Kiersten Henry, will also be available for a Q and A to answer providers’ questions about these important COVID-19 therapies.

Participation in the live webinar is limited to the first 100 participants. This session will be recorded and made available on the HAH website for on-demand viewing within one week of the live webinar date.

Please note: there is no continuing education credit associated with this informational webinar.

Dr. John Redd is an internist and medical epidemiologist who serves as the Chief Medical Officer (CMO) of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at Health and Human Services Headquarters in Washington, DC. 

Dr. Redd began his HHS career in 1994, when he became a general internist with the Indian Health Service (IHS) at the Northern Navajo Medical Center in Shiprock, New Mexico. He and his family lived on the Navajo Reservation for almost five years. He began a 20-year uniformed career with the US Public Health Service at CDC in 2000 as an Epidemic Intelligence Service officer stationed with the New Mexico Department of Health. After EIS he joined the Division of Viral Hepatitis at CDC for six years, where he was instrumental in establishing hepatitis C treatment in IHS through collaboration with Project ECHO. In a second stint with IHS, he served as Chief of the Infectious Diseases Branch of the IHS Division of Epidemiology and Disease Prevention, where he had a leadership role in the Agency response to the H1N1 influenza pandemic, and as a clinical internist at the Santa Fe Indian Hospital. He re-joined CDC in 2014 in a liaison position between CDC and Sandia National Laboratories. He has supervised EIS officers and other public health trainees since 2002 and was senior author of a Langmuir Prize-winning manuscript. 

During the CDC Ebola response in West Africa, Dr. Redd served in multiple CDC leadership positions in Sierra Leone, including Response Lead, Epidemiology Lead, and Acting Country Director. He joined the Center for Global Health’s Division of Global Health Protection in 2015, where he served as Country Manager for the Ebola-affected countries of Guinea, Sierra Leone, and Liberia. He received the Public Health Service Meritorious Service Medal and the State Department Superior Honor Award for his Ebola service in Sierra Leone. He then moved to Washington, DC to serve as the liaison officer to the ASPR from CDC’s Center for Preparedness and Response.

In 2019, Dr. Redd joined ASPR as its Chief Medical Officer. During the COVID-19 response, he was a field leader in the initial response to the pandemic in California and Japan, and then was appointed lead of the Healthcare Resilience Task Force. He then led HHS teams supervising allocation and distribution of new therapeutics, including remdesivir and monoclonal antibodies. For his service during the COVID-19 response he received the United States Public Health Service Distinguished Service Medal, the highest award presented by the United States Public Health Service. He retired as a captain in 2020.

 Dr. Redd received his BA from Harvard College and his MD from the University of Texas Southwestern Medical School in Dallas. He then completed a residency in Internal Medicine at Columbia-Presbyterian Medical Center and earned a Master of Public Health in Epidemiology degree at Columbia University in New York. He was elected a Fellow of the American College of Physicians in 2002 and was a 2010-2011 Public Health Leadership Institute Scholar. He is the co-author of over eighty publications.

Gina Smith RN CHEP NHDP-BC
Team Commander
Massachusetts-2 Disaster Medical Assistance Team (MA-2 DMAT)
HHS COVID-19 Therapeutics Team

Kiersten Henry, DNP, ACNP-BC
Nurse Practitioner, Maryland-1 DMAT
HHS COVID-19 Therapeutics Team

HAH Members: FREE (enter discount code: HAHMembermAbs and click “Apply” button)

Non-Members: $35 per person

CLICK HERE to register.